India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
How did six million mobile users decrease in one month? | Nepal Telecom and Ncell do not have the technical ability to show live World Cup football!
How did six million mobile users decrease in one month? According to the Nepal Telecommunication Authority, about six lakh mobile users have decreased within a month. According to the latest data released by the authority, it has been found that more than 580 thousand mobile users have decreased in July compared to last June. As of June, the number of mobile users in Nepal was 47,930,000. That number has reduced to 40,200,000 in July. CDMA users are not included in this number of mobile users. This is only the number of GSM mobile users.